130 related articles for article (PubMed ID: 1875338)
21. Functional interactions of L-162,313 with angiotensin II receptor subtypes and mutants.
Vianello B; Clauser E; Corvol P; Monnot C
Eur J Pharmacol; 1998 Apr; 347(1):113-8. PubMed ID: 9650856
[TBL] [Abstract][Full Text] [Related]
22. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
23. EXP597, a nonpeptide angiotensin II receptor antagonist with high affinities for the angiotensin AT1 and AT2 receptor subtypes.
Wong PC; Duncia JV; Santella JB; Smith RD; Wexler RR; Timmermans PB; Chiu AT
Eur J Pharmacol; 1994 Aug; 260(2-3):261-4. PubMed ID: 7988654
[TBL] [Abstract][Full Text] [Related]
24. Properties of [3H]LF 7-0156, a new nonpeptide antagonist radioligand for the type 1 angiotensin II receptor.
Nouet S; Dodey P; Renaut P; Marie J; Pruneau D; Larguier R; Lombard C; Bonnafous JC
Mol Pharmacol; 1994 Oct; 46(4):693-701. PubMed ID: 7969048
[TBL] [Abstract][Full Text] [Related]
25. Nonpeptide angiotensin II receptor antagonists: insurmountable angiotensin II antagonism of EXP3892 is reversed by the surmountable antagonist DuP 753.
Wong PC; Timmermans PB
J Pharmacol Exp Ther; 1991 Jul; 258(1):49-57. PubMed ID: 2072311
[TBL] [Abstract][Full Text] [Related]
26. Mapping of angiotensin II receptor subtype heterogeneity in rat brain.
Song K; Allen AM; Paxinos G; Mendelsohn FA
J Comp Neurol; 1992 Feb; 316(4):467-84. PubMed ID: 1577995
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II receptors are exclusively of the AT1 subtype in cultured human vascular smooth muscle cells.
Schachter M; Betteridge LJ; Hughes AD; Patel MK
Biochem Soc Trans; 1995 Aug; 23(3):458S. PubMed ID: 8566350
[No Abstract] [Full Text] [Related]
28. Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996).
Sircar I; Hodges JC; Quin J; Bunker AM; Winters RT; Edmunds JJ; Kostlan CR; Connolly C; Kesten SJ; Hamby JM
J Med Chem; 1993 Aug; 36(16):2253-65. PubMed ID: 8360871
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
[TBL] [Abstract][Full Text] [Related]
30. Nonpeptide angiotensin II receptor antagonists. 1. Synthesis and in vitro structure-activity relationships of 4-[[[(1H-pyrrol-1-ylacetyl)amino]phenyl]methyl]imidazole derivatives as angiotensin II receptor antagonists.
Sircar I; Winters RT; Quin J; Lu GH; Major TC; Panek RL
J Med Chem; 1993 Jun; 36(12):1735-45. PubMed ID: 8510101
[TBL] [Abstract][Full Text] [Related]
31. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
Chiu AT; McCall DE; Price WA; Wong PC; Carini DJ; Duncia JV; Wexler RR; Yoo SE; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
Cazaubon C; Gougat J; Bousquet F; Guiraudou P; Gayraud R; Lacour C; Roccon A; Galindo G; Barthelemy G; Gautret B
J Pharmacol Exp Ther; 1993 May; 265(2):826-34. PubMed ID: 8496828
[TBL] [Abstract][Full Text] [Related]
33. (Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonists.
Dhanoa DS; Bagley SW; Chang RS; Lotti VJ; Chen TB; Kivlighn SD; Zingaro GJ; Siegl PK; Chakravarty PK; Patchett AA
J Med Chem; 1993 Nov; 36(23):3738-42. PubMed ID: 8246245
[No Abstract] [Full Text] [Related]
34. A long-term receptor stimulation is requisite for angiotensin II-dependent DNA synthesis in vascular smooth muscle cells from spontaneously hypertensive rats.
Itazaki K; Hara M; Itoh N; Fujimoto M
Eur J Pharmacol; 1995 Nov; 291(3):417-25. PubMed ID: 8719428
[TBL] [Abstract][Full Text] [Related]
35. Balanced AT1/AT2 receptor antagonists. 4. XR510 and related 5-(3-amidopropanoyl)imidazoles possessing equal affinity for the AT1 and AT2 receptors.
Quan ML; Chiu AT; Ellis CD; Wong PC; Wexler RR; Timmermans PB
J Med Chem; 1995 Jul; 38(15):2938-45. PubMed ID: 7636854
[TBL] [Abstract][Full Text] [Related]
36. Dihydropyrimidine angiotensin II receptor antagonists.
Atwal KS; Ahmed SZ; Bird JE; Delaney CL; Dickinson KE; Ferrara FN; Hedberg A; Miller AV; Moreland S; O'Reilly BC
J Med Chem; 1992 Dec; 35(25):4751-63. PubMed ID: 1469703
[TBL] [Abstract][Full Text] [Related]
37. Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.
Chang RS; Lotti VJ
Mol Pharmacol; 1990 Mar; 37(3):347-51. PubMed ID: 2314387
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
[TBL] [Abstract][Full Text] [Related]
39. Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes.
Chang LL; Ashton WT; Flanagan KL; Chen TB; O'Malley SS; Zingaro GJ; Kivlighn SD; Siegl PK; Lotti VJ; Chang RS
J Med Chem; 1995 Sep; 38(19):3741-58. PubMed ID: 7562905
[TBL] [Abstract][Full Text] [Related]
40. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
Fierens FL; Vanderheyden PM; De Backer JP; Vauquelin G
Eur J Pharmacol; 1999 May; 372(2):199-206. PubMed ID: 10395100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
